audit. This is intended as a primer for all radiologists
who will be performing some of the same audit activities for the MQSA.
The Mammography Audit-Its Value
In addition to meeting requirements legislated by the MQSA, the mammography audit can serve other valuable functions.
First, it measures the mammographer's success in finding cancers, especially impalpable cancers, as compared with emerging national trends and goals [2] [3] [4] 8] . Regular review of individual and group audit data serves as a teaching tool, providing comparisons of performance and improving future outcomes [3] . Audit data can identify false-negative studies for review to determine their causes, allowing technical and interpretive shortcomings to be corrected [4, [8] [9] [10] [11] . The audit can provide data for outcomes analysis locally and nationally [3, 4, 12, 13] . Audit results could improve compliance of both referring physicians and patients with screening guidelines by increasing confidence in the screening system [3, 8] . The audit is a source of data for calculating costs per patient screened, which is valuable information to radiologists preparing for capitation contracts with health care organizations [1] . Audit data can also assist in situations requiring medicolegal defense by providing a documented profile demonstrating the radiologist s ability to evaluate benign and malignant disease meeting national goals and by providing prior reference cases similar to one in contention, which substantiate the rationale for a given interpretation [3, 4, 14, 15].
The Audit Process-An Overview
The audit involves collecting and analyzing a variety of data generated from both the mammography report and any subsequent breast biopsy. The mammography report consists of demographic information, results, and recommendations, which must be constructed in forms that allow collection of useful audit data. Demographic information such as the patient's name and age requires no special coding. Results AdditiOnal derived data of importance can also be cak uIated, as listed as part of the complete derived data in Table 3 . However, cost and time constraints and lack of availability of certain raw data may prohibit their calculation.
Calculation of the derived data in Table 1 or PPV, recall rate, tumor size, and node positivity), a mammography practice will realize benefits from a basic audit.
Desirable numerical
goals toward which the mammographer should strive are listed in Table 4 . These are based on a review of all major audits reported in scientific publications, as follows:
The sensitivity in most recently published mammography audits is greater than 85%, using the definition given in the above section [1-4, 10, 19-21,  28 ]. This range is therefore thought to be a desirable goal for which to strive ( by critically reviewing such cases, a group can benefit all its members by improving overall quality and, in turn, future outcomes.
Group review of all interval cancers, regardless of the interval between the last mammographic examination interpreted as normal and the detection of cancer, can also be of value for the same reasons [9, 10].
The third issue is one that many practices are already addressing:
review and comparison of pathology reports of breast biopsies with the corresponding mammographic examinations that prompted those biopsies. Correlations between mammographic and histologic findings in cases of both malignant and benign pathology have immeasurable teaching value. Review of cases by the mammographer and the pathologist together can further enhance the learning process for both individuals. . ldeal a blind review by one or more radiologists should be done to provide an unbiased evaluation of such cases, but even under these cond'rions, one has the unavoidable ability to see a cancer on the prior examination when the cancer is knownto exist on the present study. Mother dilemma is encountered when double reading of mammographk examinations is done and only one of the two readers correctly identifies the cancer. A problem unique to the 1-year definitlon is the situation in which a woman returns for screening less than 1 year since her last screening study and in whom a cancer is now found. The cancer is considered an FN by this definitlon, but because it has been found on the next routine screening examination, ft may be viewed as a TP.
Sources for Audit Data
None of these problems will be universally resolved. However, for the purposes of comparing a mammographer's audit data from one yearly audit period to the next, and further comparing yearly data from one mammographer or practice to the next, both the 1-year definition of the FN and the derived definition of sensitivity as described in the text remain the most objective and widely used at this time. The authors include in this group women who may not have had physical examinations prior to their mammographic examinations or in whom lesions are palpated in retrospect, as the women in both these subgroups are part of the screening pool at the time they present for their mammographic examination.
Symptomatic women are those who present for mammograpt c examinabon because of symptoms or signs of possibie breast cancer. Included in this group are women referred for evaluation because of abnonnal breast physical examinations by their clinicians but in whom screening mammograms are performed because the dinioans never related information about the abnormal physical findings to the mammographer. Because women in this subgroup are not part of the screening pool at the time they presentfor mammographic exan* abon, they should be placed with the symptomatic group for audit purposes. Even if this subgroup is included in the asymptomatic category, audit statistics will not be changed for the vast majority offacslfties, as this subgroup is small compared w i all asymptomatic women screened by mammographic examination.
